Open Access. Powered by Scholars. Published by Universities.®
80 and over;; Angiogenesis Inhibitors/*therapeutic use;; Bevacizumab/therapeutic use;; Female;; *Fluorescein Angiography;; Humans;; Intravitreal Injections;; Ranibizumab/therapeutic use;; Regional Blood Flow/physiology;; Retinal Neovascularization/diagnosis/drug therapy/*physiopathology;; Retinal Vessels/*physiology;; *Tomography
Articles 1 - 1 of 1
Full-Text Articles in Ophthalmology
En Face Oct Angiography Demonstrates Flow In Early Type 3 Neovascularization (Retinal Angiomatous Proliferation), K. K. Dansingani, J. Naysan, K. B. Freund
En Face Oct Angiography Demonstrates Flow In Early Type 3 Neovascularization (Retinal Angiomatous Proliferation), K. K. Dansingani, J. Naysan, K. B. Freund
Journal Articles
INTRODUCTION: The characteristics of type 3 neovascularization (NV), also known as retinal angiomatous proliferation, have been well described clinically, as well as with fluorescein angiography (FA), indocyanine green angiography, and optical coherence tomography (OCT). OCT angiography (OCT-A) is a novel and non-invasive technique for imaging retinal microvasculature by detecting changes, with respect to time, in reflectivity related to blood flow. METHOD: In this case series, we describe two patients who presented with type 3 NV and underwent clinical examination and multimodal imaging, including OCT-A. RESULTS: In the first patient, OCT-A demonstrated flow within two separate lesions in the same eye, …